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Abstract
Background
In this large observational study population of 105 myotonic dystrophy type 1 (DM1)
patients, we investigate whether bodyweight is a contributor of total lung capacity (TLC)
independent of the impaired inspiratory muscle strength.
Methods
Body composition was assessed using the combination of body mass index (BMI) and fat-
free mass index. Pulmonary function tests and respiratory muscle strength measurements
were performed on the same day. Patients were stratified into normal (BMI < 25 kg/m2) and
overweight (BMI 25 kg/m2) groups. Multiple linear regression was used to find significant
contributors for TLC.
Results
Overweight was present in 59% of patients, and body composition was abnormal in almost
all patients. In overweight patients, TLC was significantly (p = 2.40×10−3) decreased, com-
pared with normal-weight patients, while inspiratory muscle strength was similar in both
groups. The decrease in TLC in overweight patients was mainly due to a decrease in expira-
tory reserve volume (ERV) further illustrated by a highly significant (p = 1.33×10−10) correla-
tion between BMI and ERV. Multiple linear regression showed that TLC can be predicted
using only BMI and the forced inspiratory volume in 1 second, as these were the only signifi-
cant contributors.
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Conclusions
This study shows that, in DM1 patients, overweight further reduces lung volumes, as does
impaired inspiratory muscle strength. Additionally, body composition is abnormal in almost
all DM1 patients.
Introduction
Myotonic dystrophy type 1 (DM1) is the most frequent adult-onset muscular dystrophy, with
an estimated prevalence of 1 in 8000 individuals [1]. It is a hereditary neuromuscular disorder
with progressive muscle weakness and myotonia, caused by an unstable cytosine-thymine-gua-
nine (CTG) repeat expansion in the 30-untranslated region of the dystrophia myotonica protein
kinase (DMPK) gene [2, 3]. Also, several other organs can be involved, resulting in internal,
cardiac and respiratory pathology [4].
Aside from effects on daily quality of life due to muscle weakness [4] and fatigue [5], DM1
patients are also at increased risk for physical inactivity and being overweight [6]. In a recent
study, overweight, defined as 25 kg/m2 body mass index (BMI)< 30 kg/m2, was found in
32.5% of DM1patients, and obesity, defined as BMI 30 kg/m2, was found in 21% of DM1
patients [6]. As DM1 patients typically have reduced muscle mass, overweight will therefore
result in increased fat mass [7].
Life expectancy is markedly reduced in DM1 patients; the mean age at death is 54 years [8–
10]. The most common cause of death is respiratory failure, approximately in 50% of cases,
caused by pneumonia and overall progression of the neuromuscular disorder. Factors increas-
ing the risk of respiratory failure described in DM1 patients include reduced lung volumes,
respiratory muscle weakness, swallowing problems, (aspiration) pneumonia and obstructive
sleep apnea syndrome [8, 11–13].
Lung volumes of DM1 patients are typically described by a restrictive pattern [13], believed
to be caused by impaired respiratory muscle strength; however, in the healthy population, over-
weight and obesity are also associated with reduced lung volumes [14]. Therefore, the aim of
our study is to investigate the additional effects of overweight on lung volumes in DM1
patients, independent of impaired respiratory muscle strength.
Methods
In this retrospective observational study, body composition and pulmonary function tests were
obtained in DM1 patients who visited a chest physician of the Radboud University Medical
Center Nijmegen, the Netherlands, in the period between January 2005 and February 2013.
Several tests were performed for clinical use by an analist in the pulmonary function laboratory
and collected afterwards by the researchers to analyze the data anonymously.
Retrospectively designed studies do not need approval by the ethics committee, as stated by
the ethics committee of the Radboud University Medical Center Nijmegen. Patients who take
part in investigations for clinical use automatically agree with the use of their data (anonymized
by the main researcher) for clinical research; those patients have to disagree actively if they do
not wish that their data will be used for clinical research. Thus, as the present investigations
were performed for clinical use, there was no need for the investigators to obtain specific
informed consent. Based on the information supplied, the main researcher had access to partic-
ipant information.
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Patients were referred for evaluation of pulmonary function by a neurologist or a multidisci-
plinary team, which consists of a neurologist, rehabilitation physician, chest physician and car-
diologist, as well as several paramedics. Patients are referred to a multidisciplinary team only if
they experience limitations in everyday life. Patients with diaphragm paralysis due to neuro-
genic causes were excluded for this study. DM1 severity was measured by the disease-specific
muscular impairment rating scale (MIRS) [15]. A score of 1 reflects no muscular impairment,
2 for minimal signs, 3 for distal weakness, 4 for mild to moderate proximal weakness and 5 for
severe proximal weakness.
Body composition
BMI was calculated, and the fat-free mass was measured by bioelectrical impedance analysis
(Bodystat, 1500, Douglas, Isle of Man, UK 1997) [16]. The fat-free mass index (FFMI) was cal-
culated using a standardized equation [17]. FFMI is expressed as percentage of cut-off points,
where 100% indicates an FFMI of 16 kg/m2 for men and 15 kg/m2 for women [18]. Patients
were stratified by BMI to define overweight and obesity. As criteria for DM1 patients do not
exist yet, six different categories of body composition based on criteria used in patients with
Chronic Obstructive Pulmonary Disease (COPD) [19] were defined to investigate the existence
of an abnormal body composition: cachexia is defined as BMI< 21 kg/m2 and FFMI< 100%;
semi-starvation as BMI< 21 kg/m2 and FFMI 100%; normal weight with muscle atrophy as
21 kg/m2 BMI< 25 kg/m2 and FFMI< 100%; overweight with muscle atrophy as BMI 25
kg/m2 and FFMI< 100%; no impairment as 21 kg/m2 BMI< 25 kg/m2 and FFMI 100%;
overweight with normal muscle mass as BMI 25 kg/m2 and FFMI 100%.
Respiratory function
All pulmonary function tests were performed according to the standards of the American Tho-
racic Society/European Respiratory Society [20–23]. Patients underwent spirometry; static
lung volumes were measured by the helium dilution technique and diffusion capacity corrected
for alveolar volume (DLCO/VA). Static inspiratory (PImax) and expiratory mouth pressures
(PEmax) were also measured.
Statistical analyses
Data analysis was performed using MATLAB (R2012a, The Mathworks, Natick, MA, USA).
Pulmonary function test results have normal distributions and are presented as mean values of
predicted (%) ± standard deviation (%). MIRS scores were analyzed using non-parametric
tests, and differences in body composition and pulmonary function between patients stratified
to their MIRS score were tested using analysis of variance (ANOVA) and t-tests. Differences in
pulmonary function between normal-body-weight (BMI< 25 kg/m2) and overweight
(BMI 25 kg/m2) patients were examined using t-tests. Associations between body composi-
tion, respiratory muscle strength and lung volumes were examined using Pearson’s correlation.
Multiple linear regression with backward stepwise elimination was used to investigate the
importance of body composition and respiratory muscle strength for total lung capacity (TLC).
Only patients with measurements for all factors were included in the training model set for
multiple linear regression. After the significant contributors had been found, a test validation
set was defined as the patients left out of the training set that had measurements for the factors
that remained in the model (but had missing data for non-significant factors). The model
goodness of fit was assessed using the root-mean-square error of the training set, and the good-
ness of prediction was assessed using the root-mean-square error of prediction. A significance
threshold of p = 0.05 was used for all tests.
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Results
Patient characteristics and body composition
In this study, 106 DM1 patients were analyzed, 59.4% of whom were men. One patient was
excluded due to phrenic nerve paralysis. Patient characteristics are shown in Table 1. The
median MIRS score was 4, indicating mild to moderate proximal weakness. MIRS 1 is present
in 1% of patients, MIRS 2 in 4.8%, MIRS 3 in 22.9%, MIRS 4 in 43.8%, MIRS 5 in 18.1% and
for 9.5% of patients scores are missing. In Fig 1, the different categories of body composition
are visualized in a scatterplot of FFMI versus BMI for 71 patients, since FFMI was not mea-
sured in all patients. No impairment of body composition is present in only 4.2% of patients,
cachexia is present in 19.7%, muscle atrophy with normal body weight is present in 26.8%,
muscle atrophy with overweight is present in 14.1%, overweight with normal muscle mass is
present in 35.2% and none of the patients were classified as semi-starvation. Overweight and
obesity, without taking into account FFMI, is present in 41% and 18% of our population,
respectively.
Analyses of respiratory function
Results of pulmonary function tests are presented in Table 1 for all patients and stratified for
BMI< 25 kg/m2 and BMI 25 kg/m2; potential missing data are indicated by the number of
patients for each variable. In both the normal-weight and BMI 25 kg/m2 group, a restrictive
pulmonary function pattern is found. Also, respiratory muscle strength, both the inspiratory
and expiratory mouth pressures, is decreased significantly compared with their predicted val-
ues. The DLCO/VA is normal.
The TLC, with its different components, is visualized for both groups of BMI in Fig 2. The
outer columns show the predicted values. Patients with a BMI 25 kg/m2 have a further
reduced TLC compared with patients with BMI< 25 kg/m2, with similar values for PImax in
both groups. The decrease in TLC in the overweight group is mainly due to the decrease in
expiratory reserve volume (ERV). BMI has significant inverse correlations to ERV(r = -0.59
and p = 1.33×10−10) and functional residual capacity (FRC) (r = -0.61 and p = 3.53×10−11).
PImax is significantly correlated to forced inspiratory volume in 1 second (FIV1) (r = 0.53 and
p = 1.81×10−7) and TLC (r = 0.38 and p = 2.04×10−4). FIV1 is not correlated to BMI (r = -0.08
and p = 4.23×10−1). Respiratory function tests between different groups of MIRS score (scores
2 to 5) showed only differences in PEmax, which is significantly higher in MIRS score 3 than in
4 and 5 (p-values respectively 2.2×10−2 and 1.3×10−2). There is no difference in BMI and FFMI
between the different MIRS scores.
Multiple linear regression for TLC
Table 2 shows the correlations of body composition and inspiratory muscle strength parame-
ters with TLC. In order to investigate the joint contribution of these factors to TLC, a multiple
linear regression model was calculated. Significant contributors are covariates BMI and FIV1.
The model is described by: TLC (%pred.) = 44.54–0.55 × BMI + 0.60 × FIV1 (%pred.). In this
model, the p-values for BMI and FIV1 are 5.53×10−4 and 7.14×10−23, respectively. The valida-
tion set was defined as the patients left out of the model set who did not have missing data for
BMI, TLC and FIV1. The prediction of the validation test set fits well with its expected value
(Fig 3). The root-mean-square error of the model set is 6.51% and the root-mean-square error
of prediction is 7.39%. This demonstrates that, for an external independent test set, the TLC
can be predicted within 7.4% error using only BMI and FIV1 as predictors.
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Discussion
The most important findings of this study are that: (1) BMI is a predictor of TLC independent
from FIV; (2) TLC is further reduced in the overweight group compared with the normal-
weight group due to a reduced ERV, as respiratory muscle strength is equally diminished; and
(3) body composition is abnormal in nearly all patients.
In this exceptional large study population of 105 DM1 patients, we found that TLC and
FRC are significantly decreased further in overweight patients, compared with normal-weight
patients, due to a reduced ERV. This decrease is also found in healthy overweight individuals
[14]. Multiple linear regression was used to determine which factors (BMI, FFMI, PImax and/
or FIV1) contribute to TLC. Only BMI and FIV1 were found as significant contributors; this
means that TLC depends on whole body mass more than on fat-free mass alone. FIV1, which
can be seen as a marker of inspiratory strength as it is fully effort dependent, is more accurate
in predicting TLC than PImax is. Because we found equally decreased results for PImax and
FIV1 in both groups of BMI, the further reduction of TLC in the overweight group is likely to
be caused by the additional body weight.
Table 1. Respiratory function in 105 monotonic dystrophy type 1 (DM1) patients, normal weight (bodymass index [BMI] < 25 kg/m2) and over-
weight (BMI 25 kg/m2).
DM1 BMI < 25 kg/m2 BMI  25 kg/m2
Measurementa Mean in % (SD)b Mean in % (SD)b N = 43c Mean in % (SD)b N = 62c p-valued
Gender (% men) 60.0% 62.8% 43 58.1% 62 6.27 x 10−1
Age (years) 46.2 (12.0) 45.5 (12.4) 43 46.7 (11.8) 62 6.14 x 10−1
BMI (kg/m2) 26.4 (5.7) 21.7 (2.7) 43 29.6 (5.0) 62
FFMI (%cut-off) 96.5 (14.3) # 87.0 (10.3) 36 106.3 (10.6) 35 4.96 x 10−11 ***
FEV1 (%pred.) 82.9 (18.6) ## 87.3 (16.6) ## 42 79.8 (19.3) ## 61 3.72 x 10−2 *
VC (%pred.) 83.9 (18.9) ## 87.7 (17.1) 43 81.2 (19.8) 62 8.58 x 10−1
FEV1/VC (%) 101.1 (7.9) 100.9 (8.6) 42 101.4 (7.5) 61 7.55 x 10−1
FIV1 (%pred.) 79.6 (21.4) ## 82.4 (20.0) ## 38 78.6 (22.1) ## 60 3.81 x 10−1
FRC (%pred.) 72.3 (20.0) ## 86.6 (17.5) ## 39 62.8 (15.4) ## 59 1.52 x 10−9 ***
RV (%pred.) 71.1 (16.9) ## 79.8 (19.2) ## 40 65.3 (12.1) ## 59 8.01 x 10−5 ***
ERV (%pred.) 73.1 (36.9) ## 98.5 (32.5) 39 60.3 (31.7) ## 59 1.53 x 10−7 ***
TLC (%pred.) 79.0 (14.9) ## 84.1 (12.6) ## 41 75.4 (15.4) ## 59 2.40 x 10−3 **
DLCO/VA (%pred.) 107.4 (16.2) ## 102.8 (13.1) 38 110.6 (17.4) ## 56 1.49 x 10−2 *
PEmax (%pred.) 55.7 (23.5) ## 50.5 (21.3) ## 40 59.6 (24.5) ## 53 5.73 x 10−2
PImax (%pred.) 65.0 (23.4) ## 63.5 (23.5) ## 40 66.1 (23.5) ## 51 5.98 x 10−1
a Percentage predicted (%pred.) of FFMI (%cut-off): fat-free mass index (kg/m2) as percentage of cut-off values (normal values for mean FFMI > 16.0 kg/
m2 and for women FFMI > 15.0 kg/m2); FEV1: forced expiratory volume in 1 second; VC: vital capacity; FIV1: forced inspiratory volume in 1 second; FRC:
functional residual capacity; RV: residual volume; ERV: expiratory reserve volume; TLC: total lung capacity; DLCO/VA: diffusion capacity corrected for
alveolar volume; PEmax: maximal expiratory mouth pressure; PImax: maximal inspiratory mouth pressure.
b SD: standard deviation;
# p < 0.05;
## p < 0.001 for a paired t-test between measured and predicted values within each group.
c Number of patients with data available for each measurement.
d p-values are given for two-sample t-tests (continuous data) or Chi-squared tests (discrete data), as appropriate, between the groups of BMI.
* p < 0.05;
** p < 0.01;
*** p < 0.001.
doi:10.1371/journal.pone.0152344.t001
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Overweight in general, and therefore also in DM1, results in an increased work of breathing,
based on two physiological mechanisms. First, decreased compliance of the thoracic wall [14].
Second, enlargement of tidal volumes can be achieved only by using the inspiratory reserve vol-
ume due to reduced ERV level, which will put the respiratory muscles at a disadvantaged posi-
tion in the Starling curve, where the inspiratory muscles have to generate more tension for
equal lung volume enlargement [24]. If increased work of breathing has to be delivered when
inspiratory muscle strength is decreased, patients will develop respiratory failure sooner due to
muscle fatigue, because the fatigue threshold (PI/PImax) × (Ti/Ttot)> 0.15 will be reached ear-
lier [25]. PI is the inspiratory muscle strength needed for normal inspiration and PImax is the
maximal inspiratory muscle strength; Ti indicates the inspiratory time and the Ttot is the total
breath-cycle duration. In this study, no difference in PImax between normal-weight and over-
weight patients was found; thus, the increased work of breathing in overweight patients will
result in a higher PI/PImax ratio, and muscle fatigue will develop earlier than in normal weight
DM1 patients. To prevent the onset of muscle fatigue and the feelings of dyspnea, patients will
decrease tidal volumes, which benefit the work of breathing. However, smaller tidal volumes
result in increased dead-space ventilation, early airway closure, atelectasis and a greater likeli-
hood of respiratory infection [26]. Therefore, we argue that overweight DM1 patients are more
prone to develop respiratory failure than normal-weight patients.
Losing weight in DM1 patients may possibly result in normalizing lung volumes as is the
case in healthy obese individuals [27]. Normalized lung volumes will reduce the work of
breathing and might as a result delay the onset of respiratory failure. This hypothesis is valuable
for future studies, as respiratory failure is most common cause of death in DM1 [9, 10].
Fig 1. Scatter plot of fat-free mass index (FFMI) and bodymass index (BMI) in DM1, n = 71. The x-axis
denotes the FFMI, expressed as percentage of gender-specific cut-off points, where 100% indicates FFMI of
16 kg/m2 for men and 15 kg/m2 for women. The y-axis denotes the BMI, with horizontal lines at 21 and 25 kg/
m2. The different body compositions are defined as cachexia (BMI < 21 kg/m2 and FFMI < 100%), normal
weight with muscle atrophy (21 kg/m2 BMI < 25 kg/m2 and FFMI < 100%), normal weight with muscle
atrophy (BMI 25 kg/m2 and FFMI < 100%), no impairment (21 kg/m2 BMI < 25 kg/m2 and FFMI 100%)
and overweight (BMI 25 kg/m2 and FFMI 100%).
doi:10.1371/journal.pone.0152344.g001
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Before starting interventions for weight loss, it will be necessary to investigate the body com-
position. We found different types of abnormal body composition in nearly all patients. It is
difficult to recognize the different types of abnormal body composition using only BMI values.
We stratified patients in six categories for body composition based on BMI and FFMI [19]. An
abnormal body composition was found in 95.8% of our study population, of whommore than
50% were overweight or obese. Our results regarding BMI alone are in accordance with the
results from Gagnon et al. [6]. Physically inactivity, muscle weakness, fatigue as well as, lower
socio-economic status, lack of money, limited sports facilities and lack of motivation are
known risk factors for overweight in DM1 patients [6]. Inadequate nutritional intake in DM1
Table 2. Pearson’s correlation coefficients for the relation between total lung capacity (TLC) and
parameters of body composition and inspiratory muscle strength.
TLCCorrelation p-value
BMI (kg/m2) -0.27 7.00 x 10−3 **
FFMI (%norm) -0.05 7.13 x 10−1
PImax (%pred.) 0.38 2.04 x 10−4 ***
FIV1 (%pred.) 0.87 1.97 x 10−30 ***
BMI, body mass index; FFMI, fat-free mass index; FIV1: forced inspiratory volume in 1 second; PImax:
static inspiratory mouth pressure.
** p < 0.01,
*** p < 0.001.
doi:10.1371/journal.pone.0152344.t002
Fig 2. Stacked-bar histogram of total lung capacity (TLC) (% of predicted) in patients with normal
weight (bodymass index [BMI] < 25 kg/m2, n = 43) and overweight (BMI 25 kg/m2, n = 62), compared
with their predicted values. The black section of the stacked-bar indicates the residual volume (RV), the
gray section the expiratory reserve volume (ERV) and the white section the inspiratory capacity (IC). The RV
and ERV combined (black plus grey) is the functional reserve capacity (FRC). A restrictive pattern of
pulmonary function is shown for both groups, and the TLC is further decreased in overweight compared with
normal-weight patients, mainly due to the decreased ERV.
doi:10.1371/journal.pone.0152344.g002
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patients will also contribute to developing overweight, as fat and carbohydrate intake are often
above the daily recommended intake [28]. No prospective observational studies examining
body composition changes in DM1 patients have been published to date. We did not find a sig-
nificant difference between the overweight and normal weight DM1 patients for age.
Body composition is defined by a combination of BMI and FFMI values in 71 patients.
Missing data of FFMI are mostly from patients who visited our center in the first years of the
study time. A striking outcome of FFMI is that only overweight patients appear to have normal
values for FFMI; however, patients with overweight can still have muscle atrophy. A possible
explanation can be that skeletal muscles are trained by resistance to the excess weight, and
therefore normal values for FFMI are found only in patients with BMI 25 kg/m2. Muscle
atrophy could reflect the progression of muscular involvement in DM1 [7]. Pruna et al. [7]
investigated body composition with dual-energy X-ray absorptiometry (DEXA) and found
comparable results. However, in their population, only one patient had muscle atrophy with
overweight, and they found relatively more patients with normal values for both BMI and
FFMI. Only three of our patients (4.2%) were considered to have a non-impaired body compo-
sition; however, their BMI was very close to 25 kg/m2. Based on the MIRS scores, our patients
have greater disease severity than the population of Pruna et al.; this might also explain the dif-
ferences in body composition. These differences in patient characteristics might potentially be
explained by our inclusion criteria (see Methods), as severely affected patients are more likely
to be referred to a pulmonologist or multidisciplinary team by a neurologist.
Interventions in reducing body weight are ideally based on patients’ individual body composi-
tion and must avoid losing muscle mass. A dietitian should ideally be consulted to design a per-
sonalized diet, but increasing exercises to lose weight will likely prove to be difficult due to the
neuromuscular origin of the disorder. Losing body weight in DM1 patients by increasing
Fig 3. Multiple linear regressionmodel for predicting total lung capacity (TLC) with the significant
contributors forced inspiratory volume in 1 second (FIV1) and bodymass index (BMI). Patients in the
model and validation set are represented by gray circles and black crosses, respectively. The x-axis denotes
the TLC expressed as percentage of the predicted value for each individual and the y-axis denotes the
calculated predicted TLC (% pred.), based on FIV1 and BMI.
doi:10.1371/journal.pone.0152344.g003
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exercises requires further investigations. Cup et al. [29] found in different neuromuscular disor-
ders moderate evidence for a combination of muscle-strengthening and aerobic exercises in par-
ticipation and activities and also in several body functions; however, body weight was not defined
as an outcome. In addition, serious adverse effects of exercise were not reported [29]. Overall, the
best strategy in reducing body weight will be to prevent the development of overweight.
This large observational study is limited by some missing data and the lack of sniff nasal
inspiratory pressure measurements for evaluation of inspiratory muscle strength, which is eas-
ier to perform and therefore more preferable than mouth pressures in neuromuscular disorders
[30]. PImax maneuvers are more difficult to perform and, especially in patients with neuro-
muscular disorders, air leaking around the mouthpiece is a possibility. We took precautions to
ensure that PImax measurements were included in our data set only if no leaking of air was
reported by our laboratory technicians. Results for sniff nasal inspiratory pressure may in gen-
eral be preferable to PImax measurements. On the other hand, in the evaluation of patients
with greater disease severity, sniff nasal inspiratory pressure will possibly underestimate the
inspiratory muscle strength, as patients are unable to produce the initial negative trans-nasal
pressure to open the nostril valve [30]. Smokers were not excluded in our study, however as
smoking may result in an obstructive instead of a restrictive pulmonary function pattern, the
results will not be influenced by smoking.
Conclusion
In DM1 patients, overweight is an independent factor for predicting TLC, and contributes
independently of FIV1. Because overweight is related to increased work of breathing and inspi-
ratory muscle strength is reduced in DM1, the fatigue threshold will be reached sooner. There-
fore, muscle fatigue and the onset of respiratory failure will develop at an earlier stage in
overweight patients, especially during increased ventilator demand. Moreover, over half of
DM1 patients are overweight, and nearly all patients have an abnormal body composition. To
develop interventional strategies for weight loss, it will be important to categorize the individ-
ual type of body composition. Hence, preventing the development of overweight in DM1
patients may result in delaying respiratory failure and mortality in DM1.
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